Vice President, Medical & Evidence Strategy, Europe

PEAK LIFECYCLES HR - Europe & the US; Paris; Hybride; EUR 120 000 - 180 000; Plein temps

Résumé du poste

A leading executive search firm is seeking a Vice President, Medical & Evidence Strategy Europe for an innovative biotech company. This pivotal role involves defining the medical strategy and shaping the evidence generation landscape for breakthrough therapies in Europe. Candidates should have significant medical affairs experience, a proven track record in Europe, and expertise in scientific narrative building. The position offers a high-impact environment, enhancing patient access through strategic leadership and engagement with key stakeholders.

Prestations

High-impact executive position

Strategic interface with leadership

Influence on patient outcomes

Qualifications

• Significant experience in innovative biotech or advanced therapies.
• Demonstrated senior-level track record across Europe.
• Expertise in shaping medical strategies in early access environments.

Responsabilités

• Define and lead the European medical strategy.
• Build and direct the European evidence strategy.
• Drive scientific engagement with European KOLs and stakeholders.

Connaissances

Senior Medical Affairs experience

Scientific narrative building

Engagement with EU5 stakeholders

Evidence generation strategy

Ability to work in fast-paced environments

Description du poste

PEAK LIFECYCLES HR , dedicated to Life Sciences and global Care Markets, is part of Cornerstone International Group , ranked among the Top 40 Global Executive Search firms by Hunt Scanlon . Our global footprint combines international impact with deep local knowledge. We specialise in anticipating emerging skills, identifying new strategic expertise, and securing the leaders who will shape the future of the healthcare ecosystem

Our client is an innovative biotech company advancing through accelerated regulatory pathways and preparing its European strategic framework ahead of market readiness.

To support this critical phase, the company is now opening a Vice President, Medical & Evidence Strategy Europe role, which will lead the European medical narrative, evidence generation strategy, and early HTA readiness for a potentially breakthrough therapy

This executive role has a direct influence on future patient access, the scientific and medical positioning of the programme in Europe, and the alignment between regulatory, clinical, and evidence-based activities across the region.

Key Responsibilities

• Define and lead the European medical strategy, shaping the scientific and clinical narrative that will support accelerated approval and future market readiness.
• Build and direct the European evidence strategy (clinical, RWE, HEOR inputs) in alignment with regulatory, clinical development and global medical teams.
• Prepare and coordinate early HTA readiness activities with EU5 stakeholders, anticipating payer expectations and evidence gaps.
• Drive scientific engagement with European KOLs, advisory boards, expert committees, and early-access stakeholders.
• Partner closely with Regulatory Europe to align benefit–risk, safety, and evidence-generation narratives ahead of EMA and national-level discussions.
• Provide senior medical leadership across Europe, ensuring coherence of messaging, patient-centric benefit–risk positioning, and cross-functional alignment.

Candidate Profile

• Senior Medical Affairs / Medical Leader with significant experience in innovative biotech or advanced therapies, ideally under fast-track, conditional approval, PRIME or RMAT frameworks.
• Demonstrated senior-level track record across Europe, with direct exposure to scientific narrative building, evidence planning and early access / HTA interfaces.Demonstrated expertise in shaping medical and evidence strategies in early access or pre-commercial environments.
• Strong track record with EU5 scientific and medical stakeholders (KOLs, HTA interfaces, early-access bodies, academic networks).
• Ability to articulate a clear medical and scientific narrative for accelerated regulatory and future access pathways.
• Strategic, influential, able to operate in a high-growth, high-expectation transatlantic environment.
• Based in Europe (France, Belgium, Switzerland, UK, Germany - flexible location).

What This Role Offers

• A pivotal executive position within a high-growth biotech preparing its European footprint.
• The opportunity to shape the medical and evidence foundations ahead of accelerated approval pathways.
• A direct strategic interface with Regulatory, Clinical, Evidence and Executive leadership.
• A high-impact environment where medical strategy directly influences future access and patient outcomes.